Inpatient and Outpatient Orderable

OnkoSight Myeloid Seq Build info

Synonyms

  • ONKOSIGHT NGS MYELOID MALIGNANCIES
  • ONKOMYELO
  • LAB10522

Short Name

Onkosight NGS Myeloid Malignancies

Procedure Master Number

LAB10522

Procedure ID

111548

Clinical Info

Tumor sequencing by NGS detecting mutations in 50 genes associated with myeloid malignancies.
Mutations often have prognostic significance, may confer resistance to FDA approved
therapies, or may qualify patients for late-stage clinical trials.

Specimen Sources

 Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous Bone Marrow Bone Marrow Aspirate

Specimen Types

 Aspirate Blood Bone Marrow

Container

Sterile

Collection Instructions

Peripheral Blood - Lavender Top or  Green Top Tube
Bone Marrow - Green Top
Eppendorf tube, Unstained Slide, Formalin-fixed, Paraffin-embedded Tissue
Decalcified specimens are not recommended for NGS testing
 **  Note: Please indicate specimen type on tube **
                 Test Code TL95

Transport Instructions

Room Temperature

Specimen Stability

7 Days Refrigerated Blood samples older than 7 days can still be shipped, they will be tested if the yield and quality of DNA permit.

Methodology

Genotyping by Next Generation Sequencing
Includes:
Genes ABL1; ANKRD26; ASXL1; ATRX; BCOR; BCORL1; BRAF
CALR; CBL; CCND2; CDKN2; CEBPA: CSF3R; CUX1
DDX41: DNMT3A: ETNK1: ETV6: EZH2: FBXW7; FLT3
GATA2; HRAS; IDH1; JAK2; KDM6A; KIT; KMT2A; KRAS
MAP2K1; MPL; MYD88; NF1; NPM1; NRAS; PDGFRA
PHF6; PTEN; PTPN11; RUNX1; SETBP1; SF3B1; SRSF2
STAG2; TET2; TP53; U2AF1; WT1; ZRSR2

Days Performed

TAT: 10 - 12 Days

Performing Laboratory

Genpath BioReference

CPT

81450
81451

PDM

 1659893

Only Orderable at Locations:

 Orderable Everywhere

Results
Component Name Base Name Common Name External Name
ONKOSIGHT MYELOID SEQUENCE ONKOMYSEQ ONKO MYELO SEQ Onkosight Myeloid Sequence
MYE THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS MYEPROG MYE THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS Mye Therapeutic And Prognostic Associations
MYE INTERPRETATION SUMMARY MYEINTERP MYE INTERPRETATION SUMMARY Mye Interpretation Summary
MYE DETAILED GENETIC INTERPRETATION 1 MYEGENINT1 MYE DETAILED GENETIC INTERPRETATION 1 Mye Detailed Genetic Interpretation 1
MYE DETAILED GENETIC INTERPRETATION 2 MYEGENINT2 MYE DETAILED GENETIC INTERPRETATION 2 Mye Detailed Genetic Interpretation 2
MYE CLINICAL TRIALS 1 MYECT1 MYE CLINICAL TRIALS 1 Mye Clinical Trials 1
MYE CLINICAL TRIALS 2 MYECT2 MYE CLINICAL TRIALS 2 Mye Clinical Trials 2
MYE TECHNICAL SUMMARY MYETECH MYE TECHNICAL SUMMARY Mye Technical Summary
MYE METHODS MYEMETHOD MYE METHODS Mye Methods
MYE REFERENCES 1 MYEREF1 MYE REFERENCES 1 Mye References 1
MYE REFERENCES 2 MYEREF2 MYE REFERENCES 2 Mye References 2
MYE REPORT FOOTER MYEREPORT MYE REPORT FOOTER Mye Report Footer
MYE ADDENDUM MYE MYE ADDENDUM Mye Addendum
MYE ALLELE FREQUENCIES MYE MYE ALLELE FREQUENCIES Mye Allele Frequencies

Forms
edit